Skip to main content
Midas Edge

BrightSpring Health Services Inc

For the period ended Jun 30, 2024. Filed Aug 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 2, 2024

BTSG$69.15+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Shareholders' Equity

(In thousands, except share data)

Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total
Shares · Amount
Balances at March 31, 2024171,190,389$1,712$1,788,728$(246,069)$23,115$518$1,568,004
Net income (loss) (1)———19,919—(139)19,780
Other comprehensive loss, net of tax————(4,090)—(4,090)
Share-based compensation——15,136———15,136
Shares issued under share-based compensation plan, including tax effects107,389121———22
Shares issued for payment of acquisition99,25211,080———1,081
Balances at June 30, 2024171,397,030$1,714$1,804,965$(226,150)$19,025$379$1,599,933
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total
Shares · Amount
Balances at March 31, 2023117,883,231$1,179$778,716$(67,098)$10,981$—$723,778
Net income (1)———3,988——3,988
Other comprehensive income, net of tax————20,568—20,568
Share-based compensation——825———825
Balances at June 30, 2023117,883,231$1,179$779,541$(63,110)$31,549$—$749,159

(1) Net income (loss) to the Company for the three months ended June 30, 2024 and 2023 excludes $(339) and $(1,222), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.

Condensed Consolidated Statements of Shareholders’ Equity (continued)

(In thousands, except share data or otherwise indicated)

Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total
Shares · Amount
Balances at December 31, 2023117,857,055$1,179$771,336$(200,319)$12,544$670$585,410
Net loss (1)———(25,831)—(291)(26,122)
Other comprehensive income, net of tax————6,481—6,481
Share-based compensation——39,984———39,984
Shares issued under share-based compensation plan, including tax effects107,389121———22
Shares issued for payment of acquisition99,25211,080———1,081
Extinguishment of redeemable noncontrolling interest——14,981———14,981
Issuance of common stock on initial public offering, net of underwriting discounts and commissions, and offering-related expenses of $36.8 million53,333,334533655,952———656,485
Proceeds from stock purchase contract issued under tangible equity units, net of underwriting discounts and commissions of $9.1 million——321,611———321,611
Balances at June 30, 2024171,397,030$1,714$1,804,965$(226,150)$19,025$379$1,599,933
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · NoncontrollingInterest · Total
Shares · Amount
Balances at December 31, 2022117,860,839$1,179$778,121$(45,716)$21,192$—$754,776
Net loss (1)———(17,394)——(17,394)
Other comprehensive income, net of tax————10,357—10,357
Share-based compensation——1,275———1,275
Shares issued under share-based compensation plan, including tax effects22,392—145———145
Balances at June 30, 2023117,883,231$1,179$779,541$(63,110)$31,549$—$749,159

(1) Net loss to the Company for the six months ended June 30, 2024 and 2023 excludes $(822) and $(2,116), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.